Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J S Berek

Showing results (111-120 of 172) with videos related to

Pageof 18
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 1, 1989
Randomized trial of cyclophosphamide plus cisplatin with or without doxorubicin in ovarian carcinoma: a Gynecologic Oncology Group StudyG A Omura, B N Bundy, J S Berek, et al.
Obstetrics and Gynecology|April 1, 1983
Primary cytoreductive surgery for epithelial ovarian cancerN F Hacker, J S Berek, L D Lagasse, et al.
Gynecologic Oncology|March 1, 1991
A phase I-II trial of intraperitoneal cisplatin and alpha-interferon in patients with persistent epithelial ovarian cancerJ S Berek, C Welander, J C Schink, et al.
Gynecologic Oncology|September 1, 1991
Concurrent cisplatin and 5-fluorouracil chemotherapy and radiation therapy for advanced-stage squamous carcinoma of the vulvaJ S Berek, J M Heaps, Y S Fu, et al.
Gynecologic Oncology|April 1, 1992
Characteristics of patients with small-volume residual ovarian cancer unresponsive to cisplatin-based ip chemotherapy: lessons learned from a Gynecologic Oncology Group phase II trial of ip cisplatin and recombinant alpha-interferonM Markman, J S Berek, J A Blessing, et al.
American Journal of Obstetrics and Gynecology|April 1, 1991
Serum interleukin-6 levels correlate with disease status in patients with epithelial ovarian cancerJ S Berek, C Chung, K Kaldi, et al.
Obstetrics and Gynecology|November 1, 1987
Intraperitoneal cis-platinum as salvage therapy for refractory epithelial ovarian cancerN F Hacker, J S Berek, R G Pretorius, et al.
American Journal of Obstetrics and Gynecology|April 1, 1994
Cytokine-induced modulation of tumor suppressor gene expression in ovarian cancer cells: up-regulation of p53 gene expression and induction of apoptosis by tumor necrosis factor-alphaW H Gotlieb, J M Watson, A Rezai, et al.
Obstetrics and Gynecology|August 1, 1984
Second-look laparotomy in stage III epithelial ovarian cancer: clinical variables associated with disease statusJ S Berek, N F Hacker, L D Lagasse, et al.
Cancer|October 1, 1987
Distant metastases in epithelial ovarian carcinomaJ Dauplat, N F Hacker, R K Nieberg, et al.
Pageof 18

Showing results (111-120 of 172) with videos related to

Sort By:
Pageof 18
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 1, 1989
Randomized trial of cyclophosphamide plus cisplatin with or without doxorubicin in ovarian carcinoma: a Gynecologic Oncology Group StudyG A Omura, B N Bundy, J S Berek, et al.
Obstetrics and Gynecology|April 1, 1983
Primary cytoreductive surgery for epithelial ovarian cancerN F Hacker, J S Berek, L D Lagasse, et al.
Gynecologic Oncology|March 1, 1991
A phase I-II trial of intraperitoneal cisplatin and alpha-interferon in patients with persistent epithelial ovarian cancerJ S Berek, C Welander, J C Schink, et al.
Gynecologic Oncology|September 1, 1991
Concurrent cisplatin and 5-fluorouracil chemotherapy and radiation therapy for advanced-stage squamous carcinoma of the vulvaJ S Berek, J M Heaps, Y S Fu, et al.
Gynecologic Oncology|April 1, 1992
Characteristics of patients with small-volume residual ovarian cancer unresponsive to cisplatin-based ip chemotherapy: lessons learned from a Gynecologic Oncology Group phase II trial of ip cisplatin and recombinant alpha-interferonM Markman, J S Berek, J A Blessing, et al.
American Journal of Obstetrics and Gynecology|April 1, 1991
Serum interleukin-6 levels correlate with disease status in patients with epithelial ovarian cancerJ S Berek, C Chung, K Kaldi, et al.
Obstetrics and Gynecology|November 1, 1987
Intraperitoneal cis-platinum as salvage therapy for refractory epithelial ovarian cancerN F Hacker, J S Berek, R G Pretorius, et al.
American Journal of Obstetrics and Gynecology|April 1, 1994
Cytokine-induced modulation of tumor suppressor gene expression in ovarian cancer cells: up-regulation of p53 gene expression and induction of apoptosis by tumor necrosis factor-alphaW H Gotlieb, J M Watson, A Rezai, et al.
Obstetrics and Gynecology|August 1, 1984
Second-look laparotomy in stage III epithelial ovarian cancer: clinical variables associated with disease statusJ S Berek, N F Hacker, L D Lagasse, et al.
Cancer|October 1, 1987
Distant metastases in epithelial ovarian carcinomaJ Dauplat, N F Hacker, R K Nieberg, et al.
Pageof 18